Intressa Vascular

Intressa Vascular is a clinical-stage company developing the only comprehensive treatment for aortic dissection designed to improve patient outcomes with a low risk of ischemic complications.

Using the Allay™ Aortic Stent and its proprietary multilayer braiding technology platform, in combination with personalized procedure planning, Intressa Vascular is dedicated to helping physicians address the devastating effect of aortic dissections by providing next-generation endovascular treatment.


As the key to long-term success, we believe in investing in innovation, our people and our partners to provide patients and physicians with solutions for their unmet clinical needs.


We leverage our strengths to bring solutions to those who will most benefit. We listen and communicate with clarity and purpose to drive meaningful change.


We use our open-mind, collaborative and constructive attitude to bring high quality products to advance patient care.


At Intressa Vascular, we are a diverse team of more than 30 men and women committed to helping physicians provide better care for their patients.
With backgrounds in life sciences, healthcare, engineering and business, we come to work every day focused, energized and driven toward excellence.
We are Intressa Vascular.



Pierre Douette

Chief Executive Officer

Sébastien Collart

Chief Financial Officer

Diane Lejeune

Chief Strategy Officer

Benoit Gauthier

VP Operations

Eric Boulogne

VP Clinical

Megan Critser

Head of Global Regulatory Affairs

Board of directors

Philippe Felten


Pierre Douette

CEO, Intressa Vascular

Olivier Delporte

Independent Director

Pierre Lefebvre


Eric Brandt